Latest Articles
Allara Health Raises $26M Series B to Scale Virtual Hormonal Healthcare Platform - Femtech Insider
Allara Health Raises $26M Series B to Scale Virtual Hormonal Healthcare Platform Femtech Insider
Published: Jan. 24, 2025, 2:53 p.m.
Allara Health Raises $26 Million in Series B Funding to Revolutionize Women's Hormonal Healthcare - StreetInsider.com
Allara Health Raises $26 Million in Series B Funding to Revolutionize Women's Hormonal Healthcare StreetInsider.com
Published: Jan. 24, 2025, 2:47 p.m.
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Jan. 20, 2025, 10:56 a.m.
WellTheory Launches Program Targeting Link Between Autoimmune Disease and Hormonal Health - Femtech Insider
WellTheory Launches Program Targeting Link Between Autoimmune Disease and Hormonal Health Femtech Insider
Published: Dec. 18, 2024, 1:03 p.m.
WellTheory Announces Women’s Health Program to Address Hormonal Conditions - MedCity News
WellTheory Announces Women’s Health Program to Address Hormonal Conditions MedCity News
Published: Dec. 17, 2024, 10:48 p.m.
WellTheory launches women’s health program to address link between autoimmune disease and hormonal imbalances - substack.com
WellTheory launches women’s health program to address link between autoimmune disease and hormonal imbalances substack.com
Published: Dec. 17, 2024, 9:41 p.m.
WellTheory Launches Women’s Health Program to Address Link Between Autoimmune Disease and Hormonal Imbalances - Business Wire
WellTheory Launches Women’s Health Program to Address Link Between Autoimmune Disease and Hormonal Imbalances Business Wire
Published: Dec. 17, 2024, 2 p.m.
Management of Endometriosis-Related Pain: Comparing the Effectiveness of Hormonal Therapy, Surgical Interventions, and Complementary Therapies - Cureus
Management of Endometriosis-Related Pain: Comparing the Effectiveness of Hormonal Therapy, Surgical Interventions, and Complementary Therapies Cureus
Published: Dec. 12, 2024, 2:19 p.m.
How Hormonal Biomarkers Impact Prognosis Within EC Molecular Subgroups - Physician's Weekly
How Hormonal Biomarkers Impact Prognosis Within EC Molecular Subgroups Physician's Weekly
Published: Dec. 9, 2024, 8:49 p.m.
Study identifies key risk factors for recurrence in early endometrial cancer after hormonal therapy - KBR
Study identifies key risk factors for recurrence in early endometrial cancer after hormonal therapy KBR
Published: Dec. 3, 2024, 6:49 a.m.
Link copied to clipboard!